KKR & Co. LP diskutieren
KKR & Co. LP
WKN: A2LQV6 / Symbol: KKR / Name: KKR / Aktie / Investment Banking & Finanzdienstleistungen / Large Cap /
110,54 €
0,27 %
KKR & Co. Inc. (NYSE:KKR) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $148.00 price target on the stock.
Ratings data for KKR provided by MarketBeat
KKR & Co. Inc. (NYSE:KKR) was upgraded by analysts at BMO Capital Markets to a "strong-buy" rating.
Ratings data for KKR provided by MarketBeat
KKR & Co. Inc. (NYSE:KKR) had its price target lowered by analysts at Citigroup Inc. from $170.00 to $150.00. They now have a "buy" rating on the stock.
Ratings data for KKR provided by MarketBeat
KKR & Co. Inc. (NYSE:KKR) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $166.00 to $164.00. They now have an "outperform" rating on the stock.
Ratings data for KKR provided by MarketBeat
KKR & Co. Inc. (NYSE:KKR) had its price target lowered by analysts at Morgan Stanley from $170.00 to $166.00. They now have an "overweight" rating on the stock.
Ratings data for KKR provided by MarketBeat
KKR & Co. Inc. (NYSE:KKR) had its price target lowered by analysts at TD Cowen from $153.00 to $146.00. They now have a "buy" rating on the stock.
Ratings data for KKR provided by MarketBeat
KKR & Co. Inc. (NYSE:KKR) had its price target raised by analysts at Barclays PLC from $151.00 to $154.00. They now have an "overweight" rating on the stock.
Ratings data for KKR provided by MarketBeat
KKR & Co. Inc. (NYSE:KKR) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $176.00 price target on the stock.
Ratings data for KKR provided by MarketBeat
KKR & Co. Inc. (NYSE:KKR) had its price target raised by analysts at Barclays PLC from $154.00 to $169.00. They now have an "overweight" rating on the stock.
Ratings data for KKR provided by MarketBeat
Der Beitrag wird untersucht
Neueste Beiträge
SVB_Leerink_LLC in Ultragenyx Pharmaceutical Inc. diskutieren